PFC
EBS icon

Phocas Financial Corp’s Emergent Biosolutions EBS Stock Holding History

Phocas Financial Corp’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-31,837
Closed -$2.85M – 206
2020
Q4 		$2.85M Buy
31,837
+6,231
+24% +$572K 0.44% 97
2020
Q3 		$2.65M Sell
25,606
-56,313
-69% -$6.07M 0.45% 92
2020
Q2 		$6.48M Sell
81,919
-10,840
-12% -$808K 1.15% 18
2020
Q1 		$5.37M Sell
92,759
-8,072
-8% -$465K 1.08% 20
2019
Q4 		$5.44M Sell
100,831
-48,380
-32% -$2.62M 0.65% 69
2019
Q3 		$7.8M Sell
149,211
-284
-0.2% -$13.2K 0.83% 50
2019
Q2 		$7.22M Sell
149,495
-15,858
-10% -$760K 0.77% 57
2019
Q1 		$8.35M Sell
165,353
-37,242
-18% -$2.2M 0.84% 49
2018
Q4 		$12M Sell
202,595
-4,432
-2% -$286K 1.34% 13
2018
Q3 		$13.6M Sell
207,027
-3,839
-2% -$224K 1.19% 16
2018
Q2 		$10.6M Buy
210,866
+57,760
+38% +$3.01M 0.92% 45
2018
Q1 		$8.06M Buy
+153,106
New +$7.63M 0.73% 59

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Phocas Financial Corp's EBS Position: Q1 2021 in Review

Phocas Financial Corp sold out of Emergent Biosolutions (EBS) in Q1 2021, closing a stake of 31,837 shares — an estimated $2.85M sold.

Phocas Financial Corp first reported a position in EBS in Q1 2018 and held it in 12 quarters. The position peaked at $13.6M in Q3 2018. 339 funds tracked by Wall St. Rank hold EBS as of Q1 2021.

  • Phocas Financial Corp reported no remaining Emergent Biosolutions position as of Q1 2021 after selling out during the quarter.
  • Phocas Financial Corp sold 31,837 Emergent Biosolutions shares in Q1 2021, an estimated $2.85M.
  • Phocas Financial Corp first reported a position in Emergent Biosolutions in Q1 2018 and held it in 12 quarters.
  • Phocas Financial Corp's Emergent Biosolutions position peaked at $13.6M in Q3 2018.
  • 339 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2021.

Based on Phocas Financial Corp's 13F filing for Q1 2021, filed 22 Jun 2021.